Codeine product shortages are winding up while other medicines are set to experience longer delays
Four codeine products recently experienced shortages due to increased demand following the February upschedule, as reported in the AJP.
These included Sanofi’s Panamax Co, Prodeine 24, Prodeine Xtra and Mersyndol Forte.
The Panamax Co and Prodeine Xtra shortages are now confirmed as resolved by the TGA, while the Prodeine 24 and Mersyndol Forte shortages are expected to be resolved by the end of the month.
“We are continuing to see strong demand across our portfolio of nine Schedule 4 products which contain codeine,” a Sanofi spokesperson recently told AJP.
“These changing stock levels coincide with a number of environmental factors including the withdrawal from sale of other codeine products by other suppliers.
“We are continuing to work hard to meet the changing needs of the market and normalise stock levels for all products.”
Some long-term shortages include two versions of Arrow Pharma’s oxazepam 30mg tablet blister packs – Murelax Oxazepam and APO-Oxazepam – which are both in low supply until 30 Nov 2018 according to the TGA.
And Clopine suspension of clozapine 50 mg/mL oral liquid bottle is set to be in shortage until 30 April 2019 (phone Pfizer Australia on 1800 675 229 for more information).
Bayer’s Climara 50 estradiol 50 micrograms/day transdermal patches are in shortage reportedly until 31 July 2018, due to a manufacturing issue.
Arrow Pharma’s Capoten captopril 5mg/mL oral liquid bottle is in shortage until 19 July.
Link Medical’s Adrenaline-Link 1:10,000 1mg/10mL adrenaline (epinephrine) acid tartrate injection BP ampoules and pre filled syringes are in shortage until 20 June and 9 July respectively.
Four forms of Pfizer’s Lignocaine hydrochloride are in shortage until 2 July:
- 2% (100mg/5mL) injection BP ampoule
- 1% (50mg/5mL) injection BP ampoule
- 1% (200mg/20mL) injection BP ampoule
- 2% (400mg/20mL) injection BP ampoule
And GSK’s Bactroban mupirocin (as calcium) 20mg/g cream tube is in shortage until 30 Nov 2018 while the ointment will be experiencing shortages until 31 October (Phone GSK on 1800 033 109 for more information).
See the TGA’s Medicine Shortages Information Initiative for more information.